ORLANDO, Fla. – Adjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) increased recurrence-free survival of patients with hepatocellular carcinoma...
Clinical benefit was independent of patients’ tumor mutational burden ORLANDO, Fla. – mRNA-4157/V940, a personalized mRNA-based cancer vaccine,...
ORLANDO, Fla. – The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated...
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...
PHILADELPHIA — The American Association for Cancer Research (AACR) is proud to announce its newest class of grant recipients. Since 1993,...
Awardees to be recognized at the AACR Annual Meeting 2023 in Orlando PHILADELPHIA – The American Association for Cancer...
PHILADELPHIA – The American Association for Cancer Research (AACR) is pleased to announce the recipients of the 2023 AACR...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
Researchers partnered with Gift of Life Michigan to analyze healthy pancreata from deceased donors PHILADELPHIA – Pancreatic intraepithelial neoplasia...
NCI’s National Cancer Plan provides an updated roadmap to end cancer as we know it PHILADELPHIA – The American...